BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36442530)

  • 1. Associations of selenoprotein expression and gene methylation with the outcome of clear cell renal carcinoma.
    Ali W; Jacobs D; Zhen S; Diamond AM; Kajdacsy-Balla A
    Arch Biochem Biophys; 2023 Jan; 733():109470. PubMed ID: 36442530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.
    Zhang Y; Wang J; Liu X
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32316597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-Specific Selenocysteine Incorporation into Proteins by Genetic Engineering.
    Wang Y; Liu P; Chang J; Xu Y; Wang J
    Chembiochem; 2021 Oct; 22(20):2918-2924. PubMed ID: 33949764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of selenoproteins via genetic code expansion in mammalian cells.
    Peeler JC; Weerapana E
    Methods Enzymol; 2022; 662():143-158. PubMed ID: 35101208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Disorders Affecting the Selenocysteine Incorporation Pathway Cause Systemic Selenoprotein Deficiency.
    Schoenmakers E; Chatterjee K
    Antioxid Redox Signal; 2020 Sep; 33(7):481-497. PubMed ID: 32295391
    [No Abstract]   [Full Text] [Related]  

  • 6. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes.
    Arnér ES; Sarioglu H; Lottspeich F; Holmgren A; Böck A
    J Mol Biol; 1999 Oct; 292(5):1003-16. PubMed ID: 10512699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural elucidation of selenocysteine insertion machinery of microalgal selenoprotein T and its transcriptional analysis.
    Reshma R; Kumari S; Arumugam M
    Biotechnol Appl Biochem; 2021 Jun; 68(3):636-647. PubMed ID: 32579774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding selenoprotein function and regulation through the use of rodent models.
    Kasaikina MV; Hatfield DL; Gladyshev VN
    Biochim Biophys Acta; 2012 Sep; 1823(9):1633-42. PubMed ID: 22440326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
    Wang J; Zhang Q; Zhu Q; Liu C; Nan X; Wang F; Fang L; Liu J; Xie C; Fu S; Song B
    J Cell Physiol; 2020 Feb; 235(2):1296-1308. PubMed ID: 31273792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SecMS analysis of selenoproteins with selenocysteine insertion sequence and beyond.
    Si C; Cao Y; Zhang Y
    Methods Enzymol; 2022; 662():227-240. PubMed ID: 35101211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of structural and functional role of selenocysteine in selenoprotein H and its impact on DNA binding.
    Barage SH; Deobagkar DD; Baladhye VB
    Amino Acids; 2018 May; 50(5):593-607. PubMed ID: 29480333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma.
    Long Q; Huang C; Huang J; Meng Q; Cheng Y; Li Y; He L; Chen M; Zhang C; Wang X; Zhu W; Peng J; Shi D; Zheng F; Dong P; Deng W
    J Adv Res; 2022 Sep; 40():153-166. PubMed ID: 36100323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
    Li P; Liu J; Li J; Liu P
    Mol Biol Rep; 2019 Aug; 46(4):4377-4383. PubMed ID: 31147860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
    Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
    Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenoproteins-What unique properties can arise with selenocysteine in place of cysteine?
    Arnér ES
    Exp Cell Res; 2010 May; 316(8):1296-303. PubMed ID: 20206159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressing recombinant selenoproteins using redefinition of a single UAG codon in an RF1-depleted E. coli host strain.
    Cheng Q; Arnér ESJ
    Methods Enzymol; 2022; 662():95-118. PubMed ID: 35101220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium and selenoproteins in health and disease.
    Papp LV; Holmgren A; Khanna KK
    Antioxid Redox Signal; 2010 Apr; 12(7):793-5. PubMed ID: 19905883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic evolution of selenocysteine utilization in bacteria: a balance between selenoprotein loss and evolution of selenocysteine from redox active cysteine residues.
    Zhang Y; Romero H; Salinas G; Gladyshev VN
    Genome Biol; 2006; 7(10):R94. PubMed ID: 17054778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma.
    Fu Y; Piao C; Zhang Z; Zhu Y; Sun S; Bi J; Kong C; Ju M
    Urol Oncol; 2020 Sep; 38(9):740.e1-740.e9. PubMed ID: 32402768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural and synthetic selenoproteins.
    Metanis N; Hilvert D
    Curr Opin Chem Biol; 2014 Oct; 22():27-34. PubMed ID: 25261915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.